The Mechanisms of the RANK/RANKL Pathway in COPD Pathogenesis with a Focus on Skeletal Muscle Dysfunction.
文献摘要
Chronic obstructive pulmonary disease (COPD) is a heterogeneous pulmonary disorder characterized by persistent respiratory symptoms and significant extrapulmonary complications. Skeletal muscle dysfunction, a prominent comorbidity, severely compromises exercise capacity and quality of life and independently predicts mortality. While pharmacological therapies effectively control respiratory symptoms, they have limited efficacy against COPD-associated muscle atrophy and functional decline, and the underlying mechanisms remain poorly understood. The RANK/RANKL signaling pathway, a key mediator of muscle-bone crosstalk, is markedly upregulated in COPD and contributes to its musculoskeletal pathology. This review synthesizes current knowledge on the RANK/RANKL pathway in COPD, with a dedicated focus on its mechanistic role in driving skeletal muscle pathology. We emphasize the pathway's role in driving proteolysis via the NF-κB/ubiquitin-proteasome system, impairing myogenic regeneration, sustaining chronic low-grade inflammation, and dysregulating metabolic and calcium homeostasis. These multifaceted pathological effects enable the RANK/RANKL pathway to bridge pulmonary inflammatory injury to peripheral skeletal muscle wasting, thereby representing a plausible therapeutic target to mitigate COPD-related systemic myopathy beyond conventional pulmonary-directed treatments.